Peripheral Arterial Disease: Features

Phoenix 500: Final Results from the Phoenix Registry

02/14/2020

Meeting Exclusives

01/30/2020

“Catheter-directed intra-arterial thrombolysis is a rational and well-used method for therapy of chronic limb ischemia (CLI) patients with thrombotic occlusions of lower extremity arteries or bypass grafts,” said Ulrich Beschorner, MD.

“Catheter-directed...

01/30/2020

Vascular Disease Management

Videos

LINC 2020 Session: Latest Insights on the Safety and Efficacy of Drug-Coated Devices

01/30/2020

Dierk Scheinert, MD, and Bill Gray, MD, moderate this LINC 2020 session focusing on paclitaxel safety and with several new data releases. Featured are presentations by Drs Holden, Ouriel, Schneider, Guo, Zeller, Freisinger, and Gray.

Dierk Scheinert, MD, and Bill...

01/30/2020

Vascular Disease Management

Videos

12-Month Lutonix BTK IDE Trial Results Presented at LINC 2020

01/29/2020

Featuring Patrick J. Geraghty, MD, Washington University Medical School, and Barnes-Jewish Hospital in Saint Louis, Missouri.

Featuring Patrick J. Geraghty,...

01/29/2020

Vascular Disease Management

Meeting Exclusives

Pedal-Plantar Loop Techniques: Lessons From a Maestro

01/28/2020

Below-the-ankle revascularization and the pedal-plantar loop (PPL) technique was discussed by Marco Manzi, MD, Director of the Interventional Radiology Unit at Foot & Ankle Clinic of Policlinico Abano Terme (Padua, Italy).

Below-the-ankle...

01/28/2020

Vascular Disease Management

Meeting Exclusives

Independent Analysis of Lutonix DCB Data Reveals No Plausible Link Between Paclitaxel and Mortality

01/28/2020

Kenneth Ouriel, MD, presented the latest insights into the safety and efficacy of drug-coated devices took centre stage on Tuesday morning, with a large chunk of the session dedicated to paclitaxel safety.

Kenneth Ouriel, MD, presented...

01/28/2020

Vascular Disease Management

Interview

Improving Care of CLI and Complex PAD

01/21/2020

Vascular Disease Management spoke with Richard Neville, MD, Associate Director, INOVA Heart and Vascular Institute at INOVA Health System in Falls Church, Virginia. Dr. Neville discussed the importance of a multidisciplinary approach to...

Vascular Disease Management...

01/21/2020

Vascular Disease Management

Commentary

Commentary Regarding Katsanos et al's Meta-Analysis: The Lessons Learned Should Impose Prudence and Caution

01/14/2020

Francesco Liistro , MD;

Francesco Liistro, MD, comments on the meta-analysis presented by Katsanos et al.

Francesco Liistro, MD, comments...

01/14/2020

Vascular Disease Management

Interview

The ASPREE Trial and the Epidemic of CLI in Elderly Patients

01/03/2020

Mahmood Razavi , MD;

Mahmood Razavi, MD, reviewed the ASPREE trial and its implications for patients with CLI at the 2019 AMPutation Prevention Symposium in Chicago, Illinois. What were the goals of the ASPREE trial?

Mahmood Razavi, MD, reviewed the...

01/03/2020

Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

First Aid guidelines

AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies

11/14/2024

These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.

These are the first major...

11/14/2024

Cath Lab Digest

Late-Breaking Trials

Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/06/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...

The VIVA Foundation, a...

11/06/2024

Vascular Disease Management

Late-Breaking Trials

Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/05/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/05/2024

Vascular Disease Management

Late-Breaking Trials

Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/04/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/04/2024

Vascular Disease Management

Late-Breaking Trials

First Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/04/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/04/2024

Vascular Disease Management

Image-Guided Therapy

Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease

11/04/2024

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...

With a unique world-first...

11/04/2024

Vascular Disease Management

Pulmonary Embolism

Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism

11/04/2024

QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...

QUADRA-PE study will evaluate...

11/04/2024

Vascular Disease Management

Peripheral Arterial Disease

FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease

11/04/2024

MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...

MOUNTAIN VIEW, Calif. – November...

11/04/2024

Vascular Disease Management

Patient Awareness

Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases

10/31/2024

New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...

New survey reveals nearly one in...

10/31/2024

Vascular Disease Management

DCB

SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery

10/30/2024

Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...

Data from the prospective,...

10/30/2024

Cath Lab Digest

Peripheral Arterial Disease: Features

Stay in the Know

News

Specialties

Events

Year Round Education

HMP Global Products